This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland
Menu

Alexander Kleinsmann, PhD
Director R&D, CMC Development at Bachem AG
Speaker

Profile

Dr. Alexander Kleinsmann received his PhD in Chemistry from the University of Tübingen, Germany. He joined Bachem as a project chemist before becoming a group leader in 2019. Since 2023, he has worked as director of R&D for CMC development projects.

Agenda Sessions

  • A Second-generation Process for the Manufacturing of Liraglutide

    , 16:15
    View Session

At this event

Prev
Next
Laurent Knerr, Ph.D.
Principal Scientist
AstraZeneca

See Alexander at TIDES Europe: Oligonucleotide and Peptide Therapeutics